BRIEF-Oncomed Pharma up 62.1 pct premarket after Celgene deal

NEW YORK Tue Dec 3, 2013 8:19am EST

NEW YORK Dec 3 (Reuters) - OncoMed Pharmaceuticals Inc : * Shares up 62.1 percent premarket, to develop six cancer drugs with Celgene

Corp

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.